; (iii) a diagnostic test or screening for the diagnosis of prostate cancer, ovarian cancer, breast cancer, hypothyroidism, rheumatoid arthritis, celiac disease, vascular inflammation, cardiovascular health, strep throat, or lipoprotein (A); (iv) a haptoglobin genetic test; (v) a prediabetes and diabetes screening; (vi) an IgE allergy test; (vii) a screening or diagnostic capsule endoscopy; or (viii) any other test identified by the Secretary, including those proposed by the MA organization, as having appropriate for at-home use that is approved under section 505 of the Federal Food, Drug, and Cosmetic Act; (B) assistive telehealth consultations; (C) telehealth services; (D) fitness benefits; (E) meal benefits (beyond limited basis); (F) transportation services; (G) safety and other equipment not otherwise covered under this title; and (H) care in rural or highly rural areas (as determined in consultation with the Secretary of Agriculture using the Rural-Urban Commuting Areas coding system). (5) Other matters relating to documentation and claims review The requirements of paragraphs (2) and (3) of section 410.32(d) of title 42, Code of Federal Regulations (as in effect on the date of the enactment of this paragraph), relating to documentation and claims review, respectively, shall apply to a test described in paragraph (4)(A) and an assistive telehealth consultation. (6) Demographic data To be eligible for reimbursement under this paragraph, each claim for reimbursement shall include, with respect to each eligible Medicare beneficiary, the following demographic data: (A) Age. (B) Race and ethnicity. (C) Gender. (D) An affirmative or negative statement of the existence of any chronic condition. (E) Any other information the Secretary determines appropriate. (7) Assistive telehealth consultation In this subsection, the term assistive telehealth consultation means a telehealth service (as defined in section 1834(m)(4)(F)) that is— (A) an evaluation and management service